Trial Profile
Exploration of the weight neutral effects of insulin detemir compared to insulin glargine: A measure of satiety and calories consumed in type 1 diabetes.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 04 Oct 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
- 28 Jun 2011 Status changed from recruiting to completed, based on results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.